PYXS logo

PYXSPyxis Oncology Inc

$1.67
$0.03
(1.76%)
Today
Closed $1.67
$0.00
(0.00%)
After Hours
Updated: 07:52 PM EDT
Reported EarningsMay 14
Mkt Cap$107.7M
Vol119,536.00
News
all
press releases
Short Interest in Pyxis Oncology, Inc. (NASDAQ:PYXS) Drops By 14.7%
Pyxis Oncology, Inc. (NASDAQ:PYXS - Get Free Report) saw a significant drop in short interest in the month of April. As of April 15th, there was short interest totaling 2,269,065 shares, a drop of 14.7% from the March 31st total of 2,660,931 shares. Approximately 4.0% of the company's stock are...
MarketBeat
News Placeholder
More News
News Placeholder
Pyxis Oncology (NASDAQ:PYXS) Upgraded by Wall Street Zen to "Hold" Rating
Wall Street Zen upgraded shares of Pyxis Oncology from a "sell" rating to a "hold" rating in a research report on Monday...
MarketBeat
News Placeholder
Pyxis Oncology, Inc. (NASDAQ:PYXS) Receives Consensus Rating of "Moderate Buy" from Brokerages
Shares of Pyxis Oncology, Inc. (NASDAQ:PYXS - Get Free Report) have been assigned an average recommendation of "Moderate Buy" from the seven analysts that are covering the stock, Marketbeat reports. One equities research analyst has rated the stock with a sell rating, one has issued a hold ratin...
MarketBeat
News Placeholder
Wall Street Zen Downgrades Pyxis Oncology (NASDAQ:PYXS) to Sell
Wall Street Zen lowered Pyxis Oncology from a "hold" rating to a "sell" rating in a report on Sunday...
MarketBeat
News Placeholder
Pyxis Oncology (NASDAQ:PYXS) Stock Rating Upgraded by Wall Street Zen
Wall Street Zen upgraded Pyxis Oncology from a "sell" rating to a "hold" rating in a research note on Saturday...
MarketBeat
News Placeholder
Rachel Humphrey Sells 13,896 Shares of Pyxis Oncology (NASDAQ:PYXS) Stock
Pyxis Oncology, Inc. (NASDAQ:PYXS - Get Free Report) Director Rachel Humphrey sold 13,896 shares of the stock in a transaction on Monday, April 21st. The shares were sold at an average price of...
MarketBeat
News Placeholder
Q1 EPS Estimates for Pyxis Oncology Raised by HC Wainwright
Pyxis Oncology, Inc. (NASDAQ:PYXS - Free Report) - Analysts at HC Wainwright lifted their Q1 2026 earnings per share (EPS) estimates for shares of Pyxis Oncology in a report issued on Tuesday, March...
MarketBeat
News Placeholder
Pyxis Oncology (NASDAQ:PYXS) Director Rachel Humphrey Sells 13,896 Shares
Pyxis Oncology, Inc. (NASDAQ:PYXS - Get Free Report) Director Rachel Humphrey sold 13,896 shares of the business's stock in a transaction dated Monday, April 21st. The shares were sold at an average...
MarketBeat
News Placeholder
FY2029 EPS Estimates for Pyxis Oncology Lifted by Analyst
Pyxis Oncology, Inc. (NASDAQ:PYXS - Free Report) - Analysts at HC Wainwright upped their FY2029 earnings per share estimates for shares of Pyxis Oncology in a research report issued on Tuesday, March...
MarketBeat
News Placeholder
Stifel Nicolaus Lowers Pyxis Oncology (NASDAQ:PYXS) Price Target to $8.00
Stifel Nicolaus decreased their price target on shares of Pyxis Oncology from $9.00 to $8.00 and set a "buy" rating for the company in a research report on Tuesday...
MarketBeat
<
1
2
...
>

Advertisement|Remove ads.